$0.61
0.00%
Nasdaq, Fri, Oct 02 2026.
ISIN
US09073N2018
Symbol
BSGM

BioSig Technologies, Inc. Stock price

$0.61
-0.11 15.54% 1M
-0.55 47.22% 6M
-2.42 79.79% YTD
-4.93 88.95% 1Y
-4.39 87.76% 3Y
-25.79 97.68% 5Y
-37.14 98.38% 10Y
-79.64 99.24% 20Y
Nasdaq, Closing price Fri, Oct 02 2026
+0.00 0.00%

Is BioSig Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$2.8m
Shares outstanding
31.0m
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
- | -
P/B
-
Financial Health
Equity Ratio
-171.4%
Return on Equity
763.9%
ROCE
904.0%
ROIC
-
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$9.3m | 93,300.0%
SBC as % of FCF
-
SBC Growth 1Y
51.5%
Share Count Growth 1Y
106.7%
Shareholder Yield
-106.7%
Financials
Revenue | estimate
$10.0k | $0.0
EBITDA
$-26.5m
EBIT
$-27.1m
Net Income
$-25.9m
Free Cash Flow | ex SBC
$-4.4m | $-13.7m
Growth
Revenue | estimate
-75.0% | -100.0%
EBITDA
-44.1%
EBIT
-45.1%
Net Income
-43.1%
Free Cash Flow
54.8%
Margin
Gross
-
EBITDA
-264,900.0%
EBIT
-271,200.0%
Net
-258,700.0%
Free Cash Flow | ex SBC
-43,500.0% | -136,770.0%
More
EPS
$-0.9
FCF per Share
$-0.1
Short interest
5.9%
Employees
5
Rev per Employee
$10.0k

BioSig Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a BioSig Technologies, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a BioSig Technologies, Inc. forecast:

Buy
86%
Hold
14%

Financial data from BioSig Technologies, Inc.

Jun '25
+/-
%
0.01 0.01
75% 75%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 27 27
73% 73%
267,900%
- Research and Development Expense - -
-
-
-26 -26
44% 44%
-264,900%
- Depreciation and Amortization 0.63 0.63
103% 103%
6,300%
EBIT (Operating Income) EBIT -27 -27
45% 45%
-271,200%
Net Profit -26 -26
43% 43%
-258,700%

In millions USD.

Don't miss a Thing! We will send you all news about BioSig Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioSig Technologies, Inc. is a medical technology company. It engages in the development of a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. The firm is preparing to commercialize its PURE EP System. BioSig Technologies was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.

Head office United States
CEO Mr. Amato
Employees 5
Founded 2009
Website www.biosig.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today